Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New training aims to ease the burden on dementia caregivers

NCT ID NCT04920006

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tested a program called EnACT for family caregivers of people with dementia. The program uses group sessions where caregivers watch scenarios, practice responses, and reflect on their choices. The goal is to help caregivers feel more prepared and less stressed when dealing with difficult behaviors like agitation or depression. Thirty caregivers took part to see if the training was useful and improved their well-being.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Utah

    Salt Lake City, Utah, 84112, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Enhancing Active Caregiver Training (EnACT) – a behavioral intervention using group viewing, practice, and reflection

What this could lead to

If successful, EnACT could provide a practical, low-cost way to reduce caregiver stress and improve their ability to handle challenging dementia behaviors.

What could go wrong

This is a very small, early-stage study (30 participants) with no control group, so results may not apply broadly. The intervention is behavioral, so benefits depend on individual engagement.

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia hereditary dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.